Bioequivalence studies for GCC submission [Design Issues]

posted by professionalr – India, 2025-01-31 00:00 (102 d 07:09 ago) – Posting: # 24353
Views: 1,039

Hi friends,
Would it be acceptable to conduct bioequivalence studies for GCC submission at CRO if the facility has already been inspected by the US FDA? We don’t have separate GCC facility approval.

Thanks,
RP.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
98 visitors (0 registered, 98 guests [including 56 identified bots]).
Forum time: 08:09 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5